M. Metral

Discipline

Psychologie (3)

Type de document

Articles (5)

Co-auteur

Date

Source

Mot-clé

Patients (5) Patients (5) thérapie (4) Treatment (4) Therapeutics (4) Swiss (3) Evaluation (3) Tax assessment (3) Disabilities (3) cohorte (3) puits (2) virus (2) temps (durée) (2) infection (2) analyse (2) Aging (2) Immunodeficiency (2) Time (2) Population (2) Manufacturers' agents (2) Magnetization (2) Infection (2) Commission merchants (2) Brain (2) Aging (2) Older people (2) Analysis (2) Transfer (2) November (2) Population (2)

Documents écrit par M. Metral (5) | parle de M. Metral (0)

How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well-treated HIV-positive population?
M. Metral et al.
Cross-Sectional and Cumulative Longitudinal Central Nervous System Penetration Effectiveness Scores Are Not Associated With Neurocognitive Impairment in a Well Treated Aging Human Immunodeficiency Virus-Positive Population in Switzerland.
GMA Santos et al.
Rivastigmine decreases brain damage in HIV patients with mild cognitive deficits.
G. Perrotta et al.
The Presence of Human Immunodeficiency Virus-Associated Neurocognitive Disorders Is Associated With a Lower Adherence to Combined Antiretroviral Treatment.
S. Kamal et al. (2017)
Micro-Structural Brain Alterations in Aviremic HIV+ Patients with Minor Neurocognitive Disorders: A Multi-Contrast Study at High Field.
C. Granziera et al. (2013)